Systemic administration of 6-OHDA to rhesus monkeys upregulates HLA-DR expression in brain microvasculature

References

• FornoLSDeLanneyLEIrwinIDi MonteDLangstonJWAstrocytes and Parkinson’s diseaseProg Brain Res1992944294361287728
   PubMed Web of Science ®Google Scholar
• McGeerPLItagakiSBoyesBEMcGeerEGReactive microglia are positive for HLA-DR in the substantia nigra of Parkinson’s and Alzheimer’s disease brainsNeurology198838128512913399080
   PubMed Web of Science ®Google Scholar
• MirzaBHadbergHThomsenPMoosTThe absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson’s diseaseNeuroscience20009542543210658622
   PubMed Web of Science ®Google Scholar
• VilaMJackson-LewisVGueganCThe role of glial cells in Parkinson’s diseaseCurr Opin Neurol20011448348911470965
   PubMed Web of Science ®Google Scholar
• KostrzewaRMJacobowitzDMPharmacological actions of 6-hydroxydopaminePharmacol Rev1974261992884376244
   PubMed Web of Science ®Google Scholar
• LavertyRSharmanDFVogtMAction of 2, 4, 5- trihydroxyphenylethylamine on the storage and release of noradrenalineBr J Pharmacol Chemother19652454956014320869
   PubMed Web of Science ®Google Scholar
• EslamboliABakerHFRidleyRMAnnettLESensorimotor deficits in a unilateral intrastriatal 6-OHDA partial lesion model of Parkinson’s disease in marmoset monkeysExp Neurol200318341842914552882
   PubMed Web of Science ®Google Scholar
• IchitaniYOkamuraHMatsumotoYNagatsuIIbataYDegeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatumBrain Res19915493503531679369
   PubMed Web of Science ®Google Scholar
• Marinova-MutafchievaLSadeghianMBroomLDavisJBMedhurstADDexterDTRelationship between microglial activation and dopaminergic neuronal loss in the substantia nigra: a time course study in a 6-hydroxydopamine model of Parkinson’s diseaseJ Neurochem200911096697519549006
   PubMed Web of Science ®Google Scholar
• Rodriguez-PallaresJPargaJAMunozAReyPGuerraMJLabandeira- GarciaJLMechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6- hydroxydopamine-induced degeneration of dopaminergic neuronsJ Neurochem200710314515617573824
   PubMed Web of Science ®Google Scholar
• RoelingTADocterGJVoornPMelchersBPWoltersECGroenewegenHJEffects of unilateral 6-hydroxydopamine lesions on neuropeptide immunoreactivity in the basal ganglia of the common marmoset, Callithrix jacchus, a quantitative immunohistochemical analysisJ Chem Neuroanat199591551648588831
   PubMed Web of Science ®Google Scholar
• SauerHOertelWHProgressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6- hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the ratNeuroscience1994594014157516500
   PubMed Web of Science ®Google Scholar
• JoersVEmborgMEModeling and imaging cardiac sympathetic neurodegeneration in Parkinson’s diseaseAm J Nucl Med Mol Imaging2014412515924753981
   PubMedGoogle Scholar
• KowallNWHantrayePBrouilletEBealMFMcKeeACFerranteRJMPTP induces alpha-synuclein aggregation in the substantia nigra of baboonsNeuroreport20001121121310683860
   PubMed Web of Science ®Google Scholar
• PurisaiMGMcCormackALLangstonWJJohnstonLCDi MonteDAAlpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primatesNeurobiol Dis20052089890616006134
   PubMed Web of Science ®Google Scholar
• CarveyPMHendeyBMonahanAJThe blood-brain barrier in neurodegenerative disease: a rhetorical perspectiveJ Neurochem200911129131419659460
   PubMed Web of Science ®Google Scholar
• JoersVDilleyKRahmanSCardiac Sympathetic Denervation in 6-OHDA-Treated Nonhuman PrimatesPLoS One20149e10485025133405
   PubMed Web of Science ®Google Scholar
• JoersVSeneczkoKGoecksNCNonuniform cardiac denervation observed by 11C-meta-hydroxyephedrine PET in 6-OHDA-treated monkeysPLoS One20127e3537122539969
   PubMed Web of Science ®Google Scholar
• SwansonCEmborgMExpression of peroxisome proliferator-activated receptor-gamma in the substantia nigra of hemiparkinsonian nonhuman primatesNeurol Res20143663464624620964
   PubMed Web of Science ®Google Scholar
• EmborgMEMaSYMufsonEJAge-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeysJ Comp Neurol19984012532659822152
   PubMed Web of Science ®Google Scholar
• EmborgMEMoiranoJSchafernakKTBasal ganglia lesions after MPTP administration in rhesus monkeysNeurobiol Dis20062328128916766201
   PubMed Web of Science ®Google Scholar
• EmborgMELiuYXiJInduced pluripotent stem cell-derived neural cells survive and mature in the nonhuman primate brainCell Rep2013364665023499447
   PubMed Web of Science ®Google Scholar
• Ohshima-HosoyamaSSimmonsHAGoecksNA monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysPLoS One20127e3903622745701
   PubMed Web of Science ®Google Scholar
• EmborgMEZhangZJoersVIntracerebral transplantation of differentiated human embryonic stem cells to hemiparkinsonian monkeysCell Transplant20132283183823594934
   PubMed Web of Science ®Google Scholar
• BlandiniFArmenteroMTMartignoniEThe 6-hydroxydopamine model: news from the pastParkinsonism Relat Disord200814Suppl 2S124S12918595767
   PubMedGoogle Scholar
• SchoberAClassic toxin-induced animal models of Parkinson’s disease: 6-OHDA and MPTPCell Tissue Res200431821522415503155
   PubMed Web of Science ®Google Scholar
• LytleLDShoemakerWJCottmanKWurtmanRJLong-term effects of postnatal 6-hydroxydopamine treatment on tissue catecholamine levelsJ Pharmacol Exp Ther197218356645080034
   PubMed Web of Science ®Google Scholar
• Jaim-EtcheverryGZieherLMPermanent depletion of peripheral norepinephrine in rats treated at birth with 6-hydroxydopamineEur J Pharmacol1971132722765544082
   PubMed Web of Science ®Google Scholar
• AngelettiPUChemical sympathectomy in newborn animalsNeuropharmacology19711055595569307
   PubMed Web of Science ®Google Scholar
• EmborgMENonhuman primate models of Parkinson’s diseaseILAR J20074833935517712221
   PubMed Web of Science ®Google Scholar
• EmborgMEEvaluation of animal models of Parkinson’s disease for neuroprotective strategiesJ Neurosci Methods200413912114315488225
   PubMed Web of Science ®Google Scholar
• BendorJTLoganTPEdwardsRHThe function of alpha-synucleinNeuron2013791044106624050397
   PubMed Web of Science ®Google Scholar
• ChuYKordowerJHAge-associated increases of alpha-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: is this the target for Parkinson’s disease?Neurobiol Dis20072513414917055279
   PubMed Web of Science ®Google Scholar
• CicchettiFBrownellALWilliamsKChenYILivniEIsacsonONeuroinflammation of the nigrostriatal pathway during progressive 6-OHDA dopamine degeneration in rats monitored by immunohistochemistry and PET imagingEur J Neurosci20021599199811918659
   PubMed Web of Science ®Google Scholar
• DepinoAMEarlCKaczmarczykEMicroglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson’s diseaseEur J Neurosci2003182731274214656322
   PubMed Web of Science ®Google Scholar
• StrombergIBjorklundHDahlDJonssonGSundstromEOlsonLAstrocyte responses to dopaminergic denervations by 6- hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistryBrain Res Bull1986172252363094835
   PubMed Web of Science ®Google Scholar
• Kurkowska-JastrzebskaIWronskaAKohutnickaMCzlonkowskiACzlonkowskaAThe inflammatory reaction following 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridine intoxication in mouseExp Neurol1999156506110192776
   PubMed Web of Science ®Google Scholar
• SwansonCRJoersVBondarenkoVThe PPAR-gamma agonist pioglitazone modulates inflammation and induces neuroprotection in parkinsonian monkeysJ Neuroinflammation201189121819568
   PubMed Web of Science ®Google Scholar
• McGeerPLSchwabCParentADoudetDPresence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationAnn Neurol20035459960414595649
   PubMed Web of Science ®Google Scholar
• EnglerHDoenlenRRietherCTime-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson’s diseaseBrain Behav Immun20092351852619486644
   PubMed Web of Science ®Google Scholar
• VillaranRFEspinosa-OlivaAMSarmientoMUlcerative colitis exacerbates lipopolysaccharide-induced damage to the nigral dopaminergic system: potential risk factor in Parkinson’s diseaseJ Neurochem20101141687170020584104
   PubMed Web of Science ®Google Scholar
• VermaSNakaokeRDohguSBanksWARelease of cytokines by brain endothelial cells: a polarized response to lipopolysaccharideBrain Behav Immun20062044945516309883
   PubMed Web of Science ®Google Scholar
• BurnsTCVerfaillieCMLowWCStem cells for ischemic brain injury: a critical reviewJ Comp Neurol200951512514419399885
   PubMed Web of Science ®Google Scholar
• GendelmanHENeural immunity: friend or foe?J Neurovirol2002847447912476342
   PubMed Web of Science ®Google Scholar
• OwensTBechmannIEngelhardtBPerivascular spaces and the two steps to neuroinflammationJ Neuropathol Exp Neurol2008671113112119018243
   PubMed Web of Science ®Google Scholar
• BarciaCEmborgMEHirschECHerreroMTBlood vessels and parkinsonismFront Biosci2004927728214766365
   PubMed Web of Science ®Google Scholar